BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20545486)

  • 1. Synthesis, stability, biochemical and pharmacokinetic properties of a new potent and selective 4-oxo-β-lactam inhibitor of human leukocyte elastase.
    Mulchande J; Simões SI; Gaspar MM; Eleutério CV; Oliveira R; Cruz ME; Moreira R; Iley J
    J Enzyme Inhib Med Chem; 2011 Apr; 26(2):169-75. PubMed ID: 20545486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase.
    Mulchande J; Oliveira R; Carrasco M; Gouveia L; Guedes RC; Iley J; Moreira R
    J Med Chem; 2010 Jan; 53(1):241-53. PubMed ID: 19904934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azetidine-2,4-diones (4-oxo-beta-lactams) as scaffolds for designing elastase inhibitors.
    Mulchande J; Guedes RC; Tsang WY; Page MI; Moreira R; Iley J
    J Med Chem; 2008 Mar; 51(6):1783-90. PubMed ID: 18290604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity and selectivity in the inhibition of elastase by 3-oxo-beta-sultams and in their hydrolysis.
    Tsang WY; Ahmed N; Hemming K; Page MI
    Org Biomol Chem; 2007 Dec; 5(24):3993-4000. PubMed ID: 18043805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of leukocyte elastase, polymorphonuclear chemoinvasion, and inflammation-triggered pulmonary fibrosis by a 4-alkyliden-beta-lactam with a galloyl moiety.
    Dell'Aica I; Sartor L; Galletti P; Giacomini D; Quintavalla A; Calabrese F; Giacometti C; Brunetta E; Piazza F; Agostini C; Garbisa S
    J Pharmacol Exp Ther; 2006 Feb; 316(2):539-46. PubMed ID: 16249367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of the antielastase activity of polycyclic β-lactams.
    Monleón LM; Díez-García F; Zamora H; Anaya J; Grande M; de Diego JG; Rodríguez FD
    Bioorg Chem; 2012 Dec; 45():29-35. PubMed ID: 23064125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives.
    Portevin B; Lonchampt M; Canet E; De Nanteuil G
    J Med Chem; 1997 Jun; 40(12):1906-18. PubMed ID: 9191969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylation versus sulfonylation in the inhibition of elastase by 3-oxo-beta-sultams.
    Tsang WY; Ahmed N; Harding LP; Hemming K; Laws AP; Page MI
    J Am Chem Soc; 2005 Jun; 127(25):8946-7. PubMed ID: 15969560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clickable 4-Oxo-β-lactam-Based Selective Probing for Human Neutrophil Elastase Related Proteomes.
    Ruivo EF; Gonçalves LM; Carvalho LA; Guedes RC; Hofbauer S; Brito JA; Archer M; Moreira R; Lucas SD
    ChemMedChem; 2016 Sep; 11(18):2037-42. PubMed ID: 27465595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic study of a beta-lactam inhibitor complex with elastase at 1.84 A resolution.
    Navia MA; Springer JP; Lin TY; Williams HR; Firestone RA; Pisano JM; Doherty JB; Finke PE; Hoogsteen K
    Nature; 1987 May 7-13; 327(6117):79-82. PubMed ID: 3646481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase.
    Buynak JD; Rao AS; Ford GP; Carver C; Adam G; Geng B; Bachmann B; Shobassy S; Lackey S
    J Med Chem; 1997 Oct; 40(21):3423-33. PubMed ID: 9341917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
    Yavin EJ; Eisenstein M; Fridkin M
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anionic- and lipophilic-mediated surface binding inhibitors of human leukocyte elastase.
    Regan J; McGarry D; Bruno J; Green D; Newman J; Hsu CY; Kline J; Barton J; Travis J; Choi YM; Volz F; Pauls H; Harrison R; Zilberstein A; Ben-Sasson SA; Chang M
    J Med Chem; 1997 Oct; 40(21):3408-22. PubMed ID: 9341916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and enzymatic evaluation of N1-acyloxyalkyl- and N1-oxazolidin-2,4-dion-5-yl-substituted beta-lactams as novel inhibitors of human leukocyte elastase.
    Moreira R; Santana AB; Iley J; Neres J; Douglas KT; Horton PN; Hursthouse MB
    J Med Chem; 2005 Jul; 48(15):4861-70. PubMed ID: 16033266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH
    Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Alkyliden-beta-lactams conjugated to polyphenols: synthesis and inhibitory activity.
    Cainelli G; Galletti P; Garbisa S; Giacomini D; Sartor L; Quintavalla A
    Bioorg Med Chem; 2005 Nov; 13(22):6120-32. PubMed ID: 16084102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
    Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
    Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of human leucocyte elastase by monocyclic beta-lactams.
    Chabin R; Green BG; Gale P; Maycock AL; Weston H; Dorn CP; Finke PE; Hagmann WK; Hale JJ; MacCoss M
    Biochemistry; 1993 Aug; 32(34):8970-80. PubMed ID: 8364042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human leukocyte elastase with plasma fibronectin and its inhibition by soybean Bowman-Birk protease inhibitor.
    Larionova NI; Balabushevitch NG; Zhatikov PA
    Biochemistry (Mosc); 1998 Sep; 63(9):1078-82. PubMed ID: 9795279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacological characterization of 2-(9-(2-piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a novel, orally active elastase inhibitor.
    Kapui Z; Varga M; Urban-Szabo K; Mikus E; Szabo T; Szeredi J; Batori S; Finance O; Aranyi P
    J Pharmacol Exp Ther; 2003 May; 305(2):451-9. PubMed ID: 12606659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.